View Item 

Show simple item record

Most factor VIII B domain missense mutations are unlikely to be causative mutations for severe hemophilia A: implications for genotyping
dc.contributor.authorOgata, K.en_US
dc.contributor.authorSelvaraj, S. R.en_US
dc.contributor.authorMiao, H. Z.en_US
dc.contributor.authorPipe, Steven W.en_US
dc.date.accessioned2011-11-10T15:35:14Z
dc.date.available2012-07-12T17:42:24Zen_US
dc.date.issued2011-06en_US
dc.identifier.citationOgata, K. ; Selvaraj, S. R. ; Miao, H. Z. ; Pipe, S. W. (2011). "Most factor VIII B domain missense mutations are unlikely to be causative mutations for severe hemophilia A: implications for genotyping." Journal of Thrombosis and Haemostasis 9(6). <http://hdl.handle.net/2027.42/86976>en_US
dc.identifier.issn1538-7933en_US
dc.identifier.issn1538-7836en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/86976
dc.publisherBlackwell Publishing Ltden_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherB Domainen_US
dc.subject.otherFactor VIIIen_US
dc.subject.otherGenotypingen_US
dc.subject.otherHemophilia Aen_US
dc.subject.otherMutationsen_US
dc.titleMost factor VIII B domain missense mutations are unlikely to be causative mutations for severe hemophilia A: implications for genotypingen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pediatrics and Communicable Diseases, University of Michigan Medical Center, Ann Arbor, MI, USAen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/86976/1/j.1538-7836.2011.04268.x.pdf
dc.identifier.doi10.1111/j.1538-7836.2011.04268.xen_US
dc.identifier.sourceJournal of Thrombosis and Haemostasisen_US
dc.identifier.citedreferenceMann KG. Biochemistry and physiology of blood coagulation. Thromb Haemost 1999; 82: 165 – 74.en_US
dc.identifier.citedreferenceToole JJ, Knopf JL, Wozney JM, Sultzman LA, Buecker JL, Pittman DD, Kaufman RJ, Brown E, Shoemaker C, Orr EC, Amphlett GW, Foster WB, Coe ML, Knutson GJ, Fass DN. Molecular cloning of a cDNA encoding human antihaemophilic factor. Nature 1984; 312: 342 – 7.en_US
dc.identifier.citedreferenceVehar GA, Keyt B, Eaton D, Rodriguez H, O’Brien DP, Rotblat F, Oppermann H, Keck R, Wood WI, Harkins RN. Structure of human factor VIII. Nature 1984; 312: 337 – 42.en_US
dc.identifier.citedreferenceKaufman RJ, Wasley LC, Dorner AJ. Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells. J Biol Chem 1988; 263: 6352 – 62.en_US
dc.identifier.citedreferenceStubbs JD, Lekutis C, Singer KL, Bui A, Yuzuki D, Srinivasan U, Parry G. cDNA cloning of a mouse mammary epithelial cell surface protein reveals the existence of epidermal growth factor‐like domains linked to factor VIII‐like sequences. Proc Natl Acad Sci USA 1990; 87: 8417 – 21.en_US
dc.identifier.citedreferenced’Oiron R, Pipe SW, Jacquemin M. Mild/moderate haemophilia A: new insights into molecular mechanisms and inhibitor development. Haemophilia 2008; 14 ( Suppl. 3 ): 138 – 46.en_US
dc.identifier.citedreferencePipe SW. Functional roles of the factor VIII B domain. Haemophilia 2009; 15: 1187 – 96.en_US
dc.identifier.citedreferenceBogdanova N, Markoff A, Eisert R, Wermes C, Pollmann H, Todorova A, Chlystun M, Nowak‐Gottl U, Horst J. Spectrum of molecular defects and mutation detection rate in patients with mild and moderate hemophilia A. Hum Mutat 2007; 28: 54 – 60.en_US
dc.identifier.citedreferenceLiu J, Zhang Y, Wang H. A novel missense mutation in the B domain of factor VIII causes severe hemophilia A. Zhonghua Xue Ye Xue Za Zhi 1998; 19: 458 – 60.en_US
dc.identifier.citedreferenceBecker J, Schwaab R, Moller‐Taube A, Schwaab U, Schmidt W, Brackmann HH, Grimm T, Olek K, Oldenburg J. Characterization of the factor VIII defect in 147 patients with sporadic hemophilia A: family studies indicate a mutation type‐dependent sex ratio of mutation frequencies. Am J Hum Genet 1996; 58: 657 – 70.en_US
dc.identifier.citedreferenceHabart D, Kalabova D, Novotny M, Vorlova Z. Thirty‐four novel mutations detected in factor VIII gene by multiplex CSGE: modeling of 13 novel amino acid substitutions. J Thromb Haemost 2003; 1: 773 – 81.en_US
dc.identifier.citedreferenceSantacroce R, Acquila M, Belvini D, Castaldo G, Garagiola I, Giacomelli SH, Lombardi AM, Minuti B, Riccardi F, Salviato R, Tagliabue L, Grandone E, Margaglione M. Identification of 217 unreported mutations in the F8 gene in a group of 1,410 unselected Italian patients with hemophilia A. J Hum Genet 2008; 53: 275 – 84.en_US
dc.identifier.citedreferenceMcGinniss MJ, Kazazian HH Jr, Hoyer LW, Bi L, Inaba H, Antonarakis SE. Spectrum of mutations in CRM‐positive and CRM‐reduced hemophilia A. Genomics 1993; 15: 392 – 8.en_US
dc.identifier.citedreferenceChan V, Pang A, Chan TP, Chan VW, Chan TK. Molecular characterization of haemophilia A in southern Chinese. Br J Haematol 1996; 93: 451 – 6.en_US
dc.identifier.citedreferenceBogdanova N, Markoff A, Pollmann H, Nowak‐Gottl U, Eisert R, Wermes C, Todorova A, Eigel A, Dworniczak B, Horst J. Spectrum of molecular defects and mutation detection rate in patients with severe hemophilia A. Hum Mutat 2005; 26: 249 – 54.en_US
dc.identifier.citedreferenceBi L, Lawler AM, Antonarakis SE, High KA, Gearhart JD, Kazazian HH Jr. Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nat Genet 1995; 10: 119 – 21.en_US
dc.identifier.citedreferenceKaufman RJ. Vectors used for expression in mammalian cells. Methods Enzymol 1990; 185: 487 – 511.en_US
dc.identifier.citedreferenceQi D, Scholthof KB. A one‐step PCR‐based method for rapid and efficient site‐directed fragment deletion, insertion, and substitution mutagenesis. J Virol Methods 2008; 149: 85 – 90.en_US
dc.identifier.citedreferenceZheng L, Baumann U, Reymond JL. An efficient one‐step site‐directed and site‐saturation mutagenesis protocol. Nucleic Acids Res 2004; 32: e115.en_US
dc.identifier.citedreferencePittman DD, Alderman EM, Tomkinson KN, Wang JH, Giles AR, Kaufman RJ. Biochemical, immunological, and in vivo functional characterization of B‐domain‐deleted factor VIII. Blood 1993; 81: 2925 – 35.en_US
dc.identifier.citedreferenceLiu F, Song Y, Liu D. Hydrodynamics‐based transfection in animals by systemic administration of plasmid DNA. Gene Ther 1999; 6: 1258 – 66.en_US
dc.identifier.citedreferenceZhang G, Budker V, Wolff JA. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther 1999; 10: 1735 – 7.en_US
dc.identifier.citedreferenceKaufman RJ, Antonarakis SE, Fay PJ. Factor VIII and hemophilia A. Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 5th edn. Philadelphia: J. B. Linpincott Company, 2006: 151 – 75.en_US
dc.identifier.citedreferenceKemball‐Cook G, Tuddenham EGD, Wacey AI. The factor VIII structure and mutation resource site: HAMSTeRS version 4. Nucleic Acids Res 1998; 26: 216 – 9.en_US
dc.identifier.citedreferenceGoodeve AC, Peake IR. The molecular basis of hemophilia A: genotype‐phenotype relationships and inhibitor development. Semin Thromb Hemost 2003; 29: 23 – 30.en_US
dc.identifier.citedreferenceGouw SC, van den Berg HM. The multifactorial etiology of inhibitor development in hemophilia: genetics and environment. Semin Thromb Hemost 2009; 35: 723 – 34.en_US
dc.identifier.citedreferenceCoppola A, Margaglione M, Santagostino E, Rocino A, Grandone E, Mannucci PM, Di Minno G. Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high‐responding inhibitors. J Thromb Haemost 2009; 7: 1809 – 15.en_US
dc.identifier.citedreferenceMarkoff A, Gerke V, Bogdanova N. Combined homology modelling and evolutionary significance evaluation of missense mutations in blood clotting factor VIII to highlight aspects of structure and function. Haemophilia 2009; 15: 932 – 41.en_US
dc.identifier.citedreferenceDorner AJ, Bole DG, Kaufman RJ. The relationship of N‐linked glycosylation and heavy chain‐binding protein association with the secretion of glycoproteins. J Cell Biol 1987; 105: 2665 – 74.en_US
dc.identifier.citedreferenceViel KR, Machiah DK, Warren DM, Khachidze M, Buil A, Fernstrom K, Souto JC, Peralta JM, Smith T, Blangero J, Porter S, Warren ST, Fontcuberta J, Soria JM, Flanders WD, Almasy L, Howard TE. A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels. Blood 2007; 109: 3713 – 24.en_US
dc.identifier.citedreferenceScanavini D, Legnani C, Lunghi B, Mingozzi F, Palareti G, Bernardi F. The factor VIII D1241E polymorphism is associated with decreased factor VIII activity and not with activated protein C resistance levels. Thromb Haemost 2005; 93: 453 – 6.en_US
dc.identifier.citedreferenceNossent AY, Eikenboom JC, Vos HL, Bakker E, Tanis BC, Doggen CJ, Bertina RM, Rosendaal FR. Haplotypes encoding the factor VIII 1241 Glu variation, factor VIII levels and the risk of venous thrombosis. Thromb Haemost 2006; 95: 942 – 8.en_US
dc.identifier.citedreferenceHiguchi M, Antonarakis SE, Kasch L, Oldenburg J, Economou‐Petersen E, Olek K, Arai M, Inaba H, Kazazian HH Jr. Molecular characterization of mild‐to‐moderate hemophilia A: detection of the mutation in 25 of 29 patients by denaturing gradient gel electrophoresis. Proc Natl Acad Sci U S A 1991; 88: 8307 – 11.en_US
dc.identifier.citedreferenceHwang SH, Kim MJ, Lim JA, Kim HC, Kim HS. Profiling of factor VIII mutations in Korean haemophilia A. Haemophilia 2009; 15: 1311 – 7.en_US
dc.identifier.citedreferenceSchneppenheim R, Schroder J, Obser T, Oyen F, Schneppenheim S, Oldenburg J. The problem of novel FVIII missense mutations for haemophilia A genetic counseling. Hamostaseologie 2009; 29: 158 – 60.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1538-7836.2011.04268.x.pdf
Size:
359.8KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.